| mRNA |
AT-406 |
CTRPv2 |
pan-cancer |
AAC |
0.29 |
3e-10 |
| mRNA |
decitabine |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
6e-08 |
| mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
2e-07 |
| mRNA |
ruxolitinib |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
2e-06 |
| mRNA |
NVP-BSK805 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
2e-06 |
| mRNA |
ML239 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
8e-06 |
| mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
2e-05 |
| mRNA |
JW-74 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
4e-05 |
| mRNA |
foretinib |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
5e-05 |
| mRNA |
cabozantinib |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0002 |